Since the discovery of dendritic cells (DCs) in 1973 by Ralph Steinman, a tremendous
amount of knowledge regarding these innate immunity cells has been accumulating. Their …

Dendritic cells (DCs) play a crucial role in the induction of antigen-specific T-cell responses,
and therefore their use for the active immunotherapy of malignancies has been studied with …

Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for
harnessing the potential of a patient's own immune system to eliminate tumor cells in …

For several decades, approaches utilizing nonspecific immune stimulants have provided
evidence that the immune system, when properly activated, may eradicate cancer cells …

Dendritic cells (DCs) are the most potent antigens presenting cells in the immune system.
They have a high capacity to trigger antigen-specific immune responses and promote both …

Throughout the last decades, dendritic cell (DC)-based anti-tumor vaccines have proven to
be a safe therapeutic approach, although with inconsistent clinical results. The functional …

Background: Dendritic cells (DCs) are the most important antigen-presenting cells in the
body and play a key role in antigen recognition, uptake, processing, and presentation and …

Dendritic cells (DC) constitute a unique system of cells that induce, sustain and regulate
immune responses. Distributed as sentinels throughout the body, DC are poised to capture …

According to the GLOBOCAN reports, there were about 12.7 million cancer cases and 7.6
million cancer deaths in 2008, and the cancer burden continues to increase worldwide [1]. At …

Introduction: Dendritic cells (DCs) are the most important antigen-presenting cell population
for activating antitumor T-cell responses; therefore, they offer a unique opportunity for …